Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as α7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders
Roger B. Clark, Diana Lamppu, Lyn Libertine, et al.
Journal of Medicinal Chemistry (2014) Vol. 57, Iss. 10, pp. 3966-3983
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Recent advance in oxazole-based medicinal chemistry
Huizhen Zhang, Zhilong Zhao, Cheng‐He Zhou
European Journal of Medicinal Chemistry (2017) Vol. 144, pp. 444-492
Closed Access | Times Cited: 332
Thiazole: A promising heterocycle for the development of potent CNS active agents
Chandra Bhushan Mishra, Shikha Kumari, Manisha Tiwari
European Journal of Medicinal Chemistry (2014) Vol. 92, pp. 1-34
Closed Access | Times Cited: 172
New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs
Deniz Bağdaş, Mine Sibel Gurun, Pamela Flood, et al.
Current Neuropharmacology (2018) Vol. 16, Iss. 4, pp. 415-425
Open Access | Times Cited: 85
Piperazine skeleton in the structural modification of natural products: a review
Run-Hui Zhang, Hongyan Guo, Hao Deng, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1165-1197
Open Access | Times Cited: 77
Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors
Roger L. Papke, Nicole A. Horenstein
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 1118-1149
Open Access | Times Cited: 58
Silent agonists for α7 nicotinic acetylcholine receptors
Roger L. Papke, Marta Quadri, Alican Gulsevin
Pharmacological Research (2023) Vol. 190, pp. 106736-106736
Open Access | Times Cited: 14
Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives
Yogita Abhale, Amit V. Sasane, Abhijit Chavan, et al.
European Journal of Medicinal Chemistry (2017) Vol. 132, pp. 333-340
Closed Access | Times Cited: 48
The Minimal Pharmacophore for Silent Agonism of the α7 Nicotinic Acetylcholine Receptor
Roger L. Papke, Kinga Chojnacka, Nicole A. Horenstein
Journal of Pharmacology and Experimental Therapeutics (2014) Vol. 350, Iss. 3, pp. 665-680
Open Access | Times Cited: 43
Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists
Yu Xue, Jingshu Tang, Xiaozhuo Ma, et al.
European Journal of Medicinal Chemistry (2016) Vol. 115, pp. 94-108
Closed Access | Times Cited: 41
Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states
Roger L. Papke, Clare Stokes, M. Imad Damaj, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 11, pp. 1838-1854
Open Access | Times Cited: 32
The α7 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal
Wisam Toma, S. Lauren Kyte, Deniz Bağdaş, et al.
Experimental Neurology (2019) Vol. 320, pp. 113010-113010
Open Access | Times Cited: 28
Synthesis and biological evaluation of new 2-aryl-4-((4-aryl-1H-1,2,3-triazol-1-yl)methyl)thiazole derivatives
Vikas Shinde, Pramod P. Mahulikar, Pravin C. Mhaske, et al.
Research on Chemical Intermediates (2017) Vol. 44, Iss. 2, pp. 1247-1260
Closed Access | Times Cited: 22
Inhibitory actions of bisabolol on α7-nicotinic acetylcholine receptors
Syed M. Nurulain, Tatiana R. Prytkova, Ahmed Sultan, et al.
Neuroscience (2015) Vol. 306, pp. 91-99
Closed Access | Times Cited: 19
α-conotoxin MrIC is a biased agonist at α7 nicotinic acetylcholine receptors
Alexander Mueller, Hana Starobova, Marco Inserra, et al.
Biochemical Pharmacology (2015) Vol. 94, Iss. 2, pp. 155-163
Closed Access | Times Cited: 16
Behavioral and Molecular Basis of Cholinergic Modulation of Pain: Focus on Nicotinic Acetylcholine Receptors
Wisam Toma, Esad Ulker, Mashael Alqasem, et al.
Current topics in behavioral neurosciences (2020), pp. 153-166
Closed Access | Times Cited: 16
Identification of α7 Nicotinic Acetylcholine Receptor Silent Agonists Based on the Spirocyclic Quinuclidine‐Δ2‐Isoxazoline Scaffold: Synthesis and Electrophysiological Evaluation
Marta Quadri, Carlo Matera, Almin Silnović, et al.
ChemMedChem (2017) Vol. 12, Iss. 16, pp. 1335-1348
Open Access | Times Cited: 16
1,3-Diphenylpropan-1-Ones as Allosteric Modulators of α7 Nach Receptors with Analgesic and Antioxidant Properties
Manuel Criado, Beatriz Balsera, José Mulet, et al.
Future Medicinal Chemistry (2016) Vol. 8, Iss. 7, pp. 731-749
Open Access | Times Cited: 13
Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation
Maria Chiara Pismataro, Nicole A. Horenstein, Clare Stokes, et al.
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112669-112669
Open Access | Times Cited: 13
A Straightforward Synthesis of Six‐Membered‐Ring Heterocyclic α‐Aminophosphonic Acids from N‐Acyliminium Ions
Rubén Oswaldo Argüello‐Velasco, Grecia Katherine Sánchez‐Muñoz, José Luis Viveros‐Ceballos, et al.
Journal of Heterocyclic Chemistry (2019) Vol. 56, Iss. 7, pp. 2068-2073
Closed Access | Times Cited: 12
Iodine‐Promoted Cascade Redox Cyclization to Access 2‐Arylbenzothiazoles Using Elemental Sulfur
Yakkanti Chiranjeevi, Sujeet Gaware, Rana Chatterjee, et al.
Journal of Heterocyclic Chemistry (2024)
Closed Access | Times Cited: 1
Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation
Marta Quadri, Almin Silnović, Carlo Matera, et al.
European Journal of Medicinal Chemistry (2018) Vol. 160, pp. 207-228
Open Access | Times Cited: 10
Novel spiro[pyrrolidine-2,3′-quinoline]-2′-one derivatives containing piperazine fragment as potential chitin synthase inhibitors and antifungal agents: Design, synthesis and biological evaluation
Lige Liu, Hu Wu, Yan Long, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115777-115777
Closed Access | Times Cited: 2
Three-dimensional Quantitative Structure-activity Relationship (3DQSAR) and Molecular Docking Study of 2-((pyridin-3-yloxy)methyl) Piperazines as α7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders
Deepika Purohit, Vandana Saini, Sanjiv Kumar, et al.
Mini-Reviews in Medicinal Chemistry (2019) Vol. 20, Iss. 11, pp. 1031-1041
Closed Access | Times Cited: 5
Conformational analysis of 2-substituted piperazines
E. Adam Kallel, Colin Vangel, Daniel Elbaum
Bioorganic & Medicinal Chemistry Letters (2016) Vol. 26, Iss. 13, pp. 3010-3013
Closed Access | Times Cited: 3
A Profound Insight into the Structural Modification of Natural Bioactive Compounds Containing Piperazine Moiety: A Comprehensive Review
Bhawna Chopra, Neha Saini, Ashwani K. Dhingra
Current Bioactive Compounds (2024) Vol. 20, Iss. 2
Closed Access
Page 1 - Next Page

Scroll to top